Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alain Kummer

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Blood|May 31, 2002
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphomaRosita L ten Berge, Chris J L M Meijer, Danny F Dukers, et al.
Analytical Chemistry|June 8, 2010
In vivo bladder cancer diagnosis by high-volume Raman spectroscopyRonald O P Draga, Matthijs C M Grimbergen, Peter L M Vijverberg, et al.
Molecular and Cellular Biology|July 15, 2009
The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiationKoen M A Dreijerink, Radhika A Varier, Olivier van Beekum, et al.
Plos One|August 23, 2011
Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell deathPieter J A de Koning, J Alain Kummer, Stefanie A H de Poot, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Molecular and Cellular Endocrinology|September 5, 2009
Regulation of vitamin D receptor function in MEN1-related parathyroid adenomasKoen M A Dreijerink, Radhika A Varier, Rick van Nuland, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.
BJU International|August 22, 2022
Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trialLeonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
European Urology Oncology|June 27, 2019
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Blood|May 31, 2002
Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphomaRosita L ten Berge, Chris J L M Meijer, Danny F Dukers, et al.
Analytical Chemistry|June 8, 2010
In vivo bladder cancer diagnosis by high-volume Raman spectroscopyRonald O P Draga, Matthijs C M Grimbergen, Peter L M Vijverberg, et al.
Molecular and Cellular Biology|July 15, 2009
The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiationKoen M A Dreijerink, Radhika A Varier, Olivier van Beekum, et al.
Plos One|August 23, 2011
Intracellular serine protease inhibitor SERPINB4 inhibits granzyme M-induced cell deathPieter J A de Koning, J Alain Kummer, Stefanie A H de Poot, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 geneMaarten P Tabor, Viola M M van Houten, J Alain Kummer, et al.
Molecular and Cellular Endocrinology|September 5, 2009
Regulation of vitamin D receptor function in MEN1-related parathyroid adenomasKoen M A Dreijerink, Radhika A Varier, Rick van Nuland, et al.
Cancer Immunology, Immunotherapy : CII|November 25, 2003
Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neckDavid R Colnot, Jan C Roos, Remco de Bree, et al.
BJU International|August 22, 2022
Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trialLeonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
The Journal of Pathology|November 16, 2002
Mutated p53 as a molecular marker for the diagnosis of head and neck cancerViola M M van Houten, Maarten P Tabor, Michiel W M van den Brekel, et al.
European Urology Oncology|June 27, 2019
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?Leonie Exterkate, Olivier Wegelin, Jelle O Barentsz, et al.
Pageof 5